While the presence of tumour-infiltrating stimulatory CD103+ DCs indicates T cell engagement directly at the tumour site, regional dLN nevertheless represent the primary site of DC-T cell interaction leading to the activation of tumour-specific T cells. The gene discussed is ITGAE; the disease is neoplasm.